Tag: Novo Nordisk
Pfizer, Novo Nordisk Locked in Fierce Bidding War Over Obesity Drug...
Pfizer and Novo Nordisk Intensify Bidding War for Obesity Drug Developer Metsera
The high-stakes battle between Pfizer and Novo Nordisk for obesity drug maker Metsera...
Boardroom Battle at Novo Nordisk May Sharpen Its U.S. Growth Plan
Novo Boardroom Shake-Up Aims to Refocus on U.S. Weight-Loss Market
Boardroom tensions at Novo Nordisk, the Danish maker of Wegovy, have exposed the company’s biggest...
Novo Nordisk Ends Diabetes Cell Therapy to Save Costs
Novo Nordisk Ends Cell Therapy Program Aimed at Type 1 Diabetes Cure
Novo Nordisk has decided to shut down its cell therapy division, which had...
Novo Nordisk’s Diabetes and Obesity Drug Pipeline Still Strong, Bernstein Says
Bernstein Reiterates Outperform on Novo Nordisk: GLP-1 Portfolio Still Strong
Bernstein has reaffirmed its Outperform rating on Novo Nordisk, saying the company’s GLP-1 drug portfolio...
Novo Nordisk Lays Off 9,000 Workers as Weight-Loss Drug Competition Heats...
Novo Nordisk Cuts 9,000 Jobs in Major Restructuring Amid Weight-Loss Drug Battle
Novo Nordisk, the pharmaceutical giant behind the blockbuster weight-loss drug Wegovy, announced on...
